(-0.01%) 5 477.75 points
(-0.04%) 38 803 points
(0.03%) 19 926 points
(0.29%) $80.56
(1.11%) $2.82
(0.12%) $2 331.80
(-0.34%) $29.29
(-0.13%) $969.60
(0.02%) $0.932
(-0.12%) $10.64
(0.08%) $0.788
(-1.86%) $86.81
Live Chart Being Loaded With Signals
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States...
Stats | |
---|---|
Šios dienos apimtis | 962 288 |
Vidutinė apimtis | 2.48M |
Rinkos kapitalizacija | 3.74M |
EPS | $-4.88 ( Q1 | 2024-05-14 ) |
Kita pelno data | ( $-2.06 ) 2024-08-20 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.0900 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0230 (0.97%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-05-02 | Cleaver Heath | Buy | 10 000 | Common Stock Option (right to buy) |
2023-05-02 | Aubert Paul | Buy | 10 000 | Common Stock Option (right to buy) |
2023-05-02 | Sherwood Aline | Buy | 10 000 | Common Stock Option (right to buy) |
2023-05-02 | Morris Douglas P | Buy | 13 000 | Common Stock Option (right to buy) |
2023-05-02 | Nielsen Peter Henry | Buy | 105 000 | Common Stock Option (right to buy) |
INSIDER POWER |
---|
100.00 |
Last 88 transactions |
Buy: 10 429 808 | Sell: 661 335 |
Tūris Koreliacija
Bio Path Holdings Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
SIRI | 0.963 |
FXNC | 0.962 |
AKAN | 0.961 |
CNTG | 0.958 |
PACB | 0.956 |
UONEK | 0.955 |
GP | 0.954 |
QNRX | 0.953 |
ACAD | 0.952 |
APTO | 0.952 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
OZEM | -1 |
APP | -0.961 |
SHLD | -0.961 |
PNTG | -0.96 |
RNA | -0.954 |
ARYD | -0.953 |
SWAV | -0.953 |
FANG | -0.952 |
IBKR | -0.949 |
PPC | -0.949 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Bio Path Holdings Inc Koreliacija - Valiuta/Žaliavos
Bio Path Holdings Inc Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $0 |
Bruto pelnas: | $-178 000 (0.00 %) |
EPS: | $-33.64 |
FY | 2023 |
Pajamos: | $0 |
Bruto pelnas: | $-178 000 (0.00 %) |
EPS: | $-33.64 |
FY | 2022 |
Pajamos: | $0 |
Bruto pelnas: | $-178 000 (0.00 %) |
EPS: | $-38.03 |
FY | 2021 |
Pajamos: | $0.00 |
Bruto pelnas: | $0.00 (0.00 %) |
EPS: | $-1.550 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Bio Path Holdings Inc
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing Liposomal Bcl-2 for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; Liposomal STAT3 that is in preclinical stage for the treatment of pancreatic cancer, non-small cell lung cancer, and AML; and prexigebersen-A for various solid tumors. Bio-Path Holdings, Inc. was founded in 2007 and is based in Bellaire, Texas.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.